Efficacy of Yishen Huashi Granules Combined with Linagliptin Tablets on Blood Glucose and Renal Function in Patients with Type 2 Diabetic Nephropathy

Table 1

Comparison of general data (n = 35).

Observation indexes	Control group	Research group	X ^2/t
Age (years)	58.51 ± 8.30	58.34 ± 8.40	0.085	0.932
Genders			0.238	0.626
Male	20 (57.14)	22 (62.86)
Female	15 (42.86)	13 (37.14)
Duration of diabetes (years)	5.89 ± 1.12	6.00 ± 1.15	0.405	0.687
FPG (mmol/L)	10.25 ± 0.67	10.34 ± 0.71	0.545	0.587
2h-PBG (mmol/L)	12.56 ± 1.97	12.50 ± 1.88	0.130	0.897
HbA1c (%)	8.80 ± 1.47	8.78 ± 1.50	0.056	0.955
TC (mmol/L)	5.47 ± 0.65	5.48 ± 0.53	0.071	0.944
TG (mmol/L)	2.08 ± 1.40	2.13 ± 0.38	0.204	0.839
SCr (umol/L)	73.05 ± 16.85	72.96 ± 17.10	0.22	0.982
BUN (mmol/L)	8.53 ± 5.59	8.47 ± 5.41	0.046	0.964
Concomitant risk factors
Hypertension	29 (82.86)	31 (88.57)	0.467	0.495
Hyperlipidemia	20 (57.14)	19 (54.29)	0.058	0.810
BMI (kg/m^2)	20.86 ± 2.01	21.05 ± 2.10	0.387	0.700
TNF-α (ng/L)	141.84 ± 24.10	142.48 ± 23.71	0.112	0.911
IL-6 (ng/L)	60.07 ± 8.37	60.20 ± 8.85	0.063	0.950
Hs-CRP (mg/L)	7.55 ± 1.85	7.48 ± 1.83	0.159	0.874